Decorin suppresses stemness and migration potential of malignant peripheral nerve sheath tumor through inhibiting epidermal growth factor receptor signaling

Cancer stem cells (CSCs) play pivotal roles in the growth, invasion, metastasis, chemo-resistance in malignant peripheral nerve sheath tumor (MPNST). The current characterization of CSCs in MPNST is not complete. Decorin is a critical regulator of microenvironment, but its expression and function in...

Full description

Saved in:
Bibliographic Details
Published inBiochimica et biophysica acta. Molecular basis of disease Vol. 1870; no. 5; p. 167181
Main Authors Jia, Xiaotian, Chen, Lin, Yu, Cong
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.06.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Cancer stem cells (CSCs) play pivotal roles in the growth, invasion, metastasis, chemo-resistance in malignant peripheral nerve sheath tumor (MPNST). The current characterization of CSCs in MPNST is not complete. Decorin is a critical regulator of microenvironment, but its expression and function in CSCs of MPNST has not been studied. In the current study, Decorin levels and its relationship with lung and liver metastasis were determined in clinical specimens. Decorin expression in CD133-positive or CD44-positive CSCs was analyzed by RT-qPCR on cytospun MPNST cells after flow cytometry-based cell sorting. Decorin-positive cells were separated from Decorin-negative cells in transfected MPNST cell lines using a designed plasmid expressing red fluorescent protein (RFP) under a Decorin promoter. Tumor sphere formation, tumor growth, cell invasion, cell migration, and the resistance to chemotherapy-induced apoptosis were determined on Decorin-positive versus Decorin-negative MPNST cells. In vivo tumor growth was analyzed in mice receiving subcutaneous transplantation of Decorin-positive versus Decorin-negative MPNSTs. We found that Decorin levels were significantly downregulated in MPNST specimens, compared to non-tumorous adjacent tissue. Significantly lower Decorin levels were detected in MPNSTs with lung or liver metastasis compared to those without. Poorer patient survival was detected in Decorin-low MPNST, compared to Decorin-high subjects. More Decorin-negative cells were detected in CD133-positive MPNST cells than CD133-negative MPNST cells, and in CD44-positive MPNST cells than in CD44-negative MPNST cells. Compared to Decorin-positive MPNST cells, Decorin-negative MPNST cells generated significantly more tumor spheres in culture, were more invasive and migratory, and were more resistant to chemotherapy-induced apoptosis, likely due to the inhibition of epidermal growth factor receptor signaling by Decorin. Decorin-negative MPNST cells grew significantly larger tumor in vivo. Thus, depletion of Decorin may occur in CSCs in MPNSTs, serving possibly as a new therapeutic target. [Display omitted] •Decorin is reduced expression in malignant MPNSTs, particularly in those with lung or liver metastasis.•Lower Decorin levels correlate with poorer patient survival.•Loss of Decorin was observed in CSCs of MPNSTs.•Loss of Decorin likely regulate stemness of CSCs of MPNST cells through EGFR signaling.
AbstractList Cancer stem cells (CSCs) play pivotal roles in the growth, invasion, metastasis, chemo-resistance in malignant peripheral nerve sheath tumor (MPNST). The current characterization of CSCs in MPNST is not complete. Decorin is a critical regulator of microenvironment, but its expression and function in CSCs of MPNST has not been studied. In the current study, Decorin levels and its relationship with lung and liver metastasis were determined in clinical specimens. Decorin expression in CD133-positive or CD44-positive CSCs was analyzed by RT-qPCR on cytospun MPNST cells after flow cytometry-based cell sorting. Decorin-positive cells were separated from Decorin-negative cells in transfected MPNST cell lines using a designed plasmid expressing red fluorescent protein (RFP) under a Decorin promoter. Tumor sphere formation, tumor growth, cell invasion, cell migration, and the resistance to chemotherapy-induced apoptosis were determined on Decorin-positive versus Decorin-negative MPNST cells. In vivo tumor growth was analyzed in mice receiving subcutaneous transplantation of Decorin-positive versus Decorin-negative MPNSTs. We found that Decorin levels were significantly downregulated in MPNST specimens, compared to non-tumorous adjacent tissue. Significantly lower Decorin levels were detected in MPNSTs with lung or liver metastasis compared to those without. Poorer patient survival was detected in Decorin-low MPNST, compared to Decorin-high subjects. More Decorin-negative cells were detected in CD133-positive MPNST cells than CD133-negative MPNST cells, and in CD44-positive MPNST cells than in CD44-negative MPNST cells. Compared to Decorin-positive MPNST cells, Decorin-negative MPNST cells generated significantly more tumor spheres in culture, were more invasive and migratory, and were more resistant to chemotherapy-induced apoptosis, likely due to the inhibition of epidermal growth factor receptor signaling by Decorin. Decorin-negative MPNST cells grew significantly larger tumor in vivo. Thus, depletion of Decorin may occur in CSCs in MPNSTs, serving possibly as a new therapeutic target.
Cancer stem cells (CSCs) play pivotal roles in the growth, invasion, metastasis, chemo-resistance in malignant peripheral nerve sheath tumor (MPNST). The current characterization of CSCs in MPNST is not complete. Decorin is a critical regulator of microenvironment, but its expression and function in CSCs of MPNST has not been studied. In the current study, Decorin levels and its relationship with lung and liver metastasis were determined in clinical specimens. Decorin expression in CD133-positive or CD44-positive CSCs was analyzed by RT-qPCR on cytospun MPNST cells after flow cytometry-based cell sorting. Decorin-positive cells were separated from Decorin-negative cells in transfected MPNST cell lines using a designed plasmid expressing red fluorescent protein (RFP) under a Decorin promoter. Tumor sphere formation, tumor growth, cell invasion, cell migration, and the resistance to chemotherapy-induced apoptosis were determined on Decorin-positive versus Decorin-negative MPNST cells. In vivo tumor growth was analyzed in mice receiving subcutaneous transplantation of Decorin-positive versus Decorin-negative MPNSTs. We found that Decorin levels were significantly downregulated in MPNST specimens, compared to non-tumorous adjacent tissue. Significantly lower Decorin levels were detected in MPNSTs with lung or liver metastasis compared to those without. Poorer patient survival was detected in Decorin-low MPNST, compared to Decorin-high subjects. More Decorin-negative cells were detected in CD133-positive MPNST cells than CD133-negative MPNST cells, and in CD44-positive MPNST cells than in CD44-negative MPNST cells. Compared to Decorin-positive MPNST cells, Decorin-negative MPNST cells generated significantly more tumor spheres in culture, were more invasive and migratory, and were more resistant to chemotherapy-induced apoptosis, likely due to the inhibition of epidermal growth factor receptor signaling by Decorin. Decorin-negative MPNST cells grew significantly larger tumor in vivo. Thus, depletion of Decorin may occur in CSCs in MPNSTs, serving possibly as a new therapeutic target. [Display omitted] •Decorin is reduced expression in malignant MPNSTs, particularly in those with lung or liver metastasis.•Lower Decorin levels correlate with poorer patient survival.•Loss of Decorin was observed in CSCs of MPNSTs.•Loss of Decorin likely regulate stemness of CSCs of MPNST cells through EGFR signaling.
Cancer stem cells (CSCs) play pivotal roles in the growth, invasion, metastasis, chemo-resistance in malignant peripheral nerve sheath tumor (MPNST). The current characterization of CSCs in MPNST is not complete. Decorin is a critical regulator of microenvironment, but its expression and function in CSCs of MPNST has not been studied. In the current study, Decorin levels and its relationship with lung and liver metastasis were determined in clinical specimens. Decorin expression in CD133-positive or CD44-positive CSCs was analyzed by RT-qPCR on cytospun MPNST cells after flow cytometry-based cell sorting. Decorin-positive cells were separated from Decorin-negative cells in transfected MPNST cell lines using a designed plasmid expressing red fluorescent protein (RFP) under a Decorin promoter. Tumor sphere formation, tumor growth, cell invasion, cell migration, and the resistance to chemotherapy-induced apoptosis were determined on Decorin-positive versus Decorin-negative MPNST cells. In vivo tumor growth was analyzed in mice receiving subcutaneous transplantation of Decorin-positive versus Decorin-negative MPNSTs. We found that Decorin levels were significantly downregulated in MPNST specimens, compared to non-tumorous adjacent tissue. Significantly lower Decorin levels were detected in MPNSTs with lung or liver metastasis compared to those without. Poorer patient survival was detected in Decorin-low MPNST, compared to Decorin-high subjects. More Decorin-negative cells were detected in CD133-positive MPNST cells than CD133-negative MPNST cells, and in CD44-positive MPNST cells than in CD44-negative MPNST cells. Compared to Decorin-positive MPNST cells, Decorin-negative MPNST cells generated significantly more tumor spheres in culture, were more invasive and migratory, and were more resistant to chemotherapy-induced apoptosis, likely due to the inhibition of epidermal growth factor receptor signaling by Decorin. Decorin-negative MPNST cells grew significantly larger tumor in vivo. Thus, depletion of Decorin may occur in CSCs in MPNSTs, serving possibly as a new therapeutic target.Cancer stem cells (CSCs) play pivotal roles in the growth, invasion, metastasis, chemo-resistance in malignant peripheral nerve sheath tumor (MPNST). The current characterization of CSCs in MPNST is not complete. Decorin is a critical regulator of microenvironment, but its expression and function in CSCs of MPNST has not been studied. In the current study, Decorin levels and its relationship with lung and liver metastasis were determined in clinical specimens. Decorin expression in CD133-positive or CD44-positive CSCs was analyzed by RT-qPCR on cytospun MPNST cells after flow cytometry-based cell sorting. Decorin-positive cells were separated from Decorin-negative cells in transfected MPNST cell lines using a designed plasmid expressing red fluorescent protein (RFP) under a Decorin promoter. Tumor sphere formation, tumor growth, cell invasion, cell migration, and the resistance to chemotherapy-induced apoptosis were determined on Decorin-positive versus Decorin-negative MPNST cells. In vivo tumor growth was analyzed in mice receiving subcutaneous transplantation of Decorin-positive versus Decorin-negative MPNSTs. We found that Decorin levels were significantly downregulated in MPNST specimens, compared to non-tumorous adjacent tissue. Significantly lower Decorin levels were detected in MPNSTs with lung or liver metastasis compared to those without. Poorer patient survival was detected in Decorin-low MPNST, compared to Decorin-high subjects. More Decorin-negative cells were detected in CD133-positive MPNST cells than CD133-negative MPNST cells, and in CD44-positive MPNST cells than in CD44-negative MPNST cells. Compared to Decorin-positive MPNST cells, Decorin-negative MPNST cells generated significantly more tumor spheres in culture, were more invasive and migratory, and were more resistant to chemotherapy-induced apoptosis, likely due to the inhibition of epidermal growth factor receptor signaling by Decorin. Decorin-negative MPNST cells grew significantly larger tumor in vivo. Thus, depletion of Decorin may occur in CSCs in MPNSTs, serving possibly as a new therapeutic target.
ArticleNumber 167181
Author Yu, Cong
Chen, Lin
Jia, Xiaotian
Author_xml – sequence: 1
  givenname: Xiaotian
  surname: Jia
  fullname: Jia, Xiaotian
– sequence: 2
  givenname: Lin
  surname: Chen
  fullname: Chen, Lin
  email: 447836459@qq.com
– sequence: 3
  givenname: Cong
  surname: Yu
  fullname: Yu, Cong
  email: drcongyu@yeah.net
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38653361$$D View this record in MEDLINE/PubMed
BookMark eNqFkc1u1TAQhS1URG8Lb4CQl2xysWPHN2GBhEoLSJXYgMTO8s8k8VViB9sp6rvwsPiSdsMCZjOj0XfO4pwLdOaDB4ReUrKnhIo3x73Wyrq0r0nN91QcaEufoB1tD11VC_L9DO1IVzcV56w7RxcpHUkZcSDP0DlrRcOYoDv06wOYEJ3HaV2WCClBwinD7MuJlbd4dkNU2QWPl5DBZ6cmHHo8q8kNXvmMF4huGSGWv4d4BziNoPKI8zqHiPMYwzqM2PnRaZedHzAszkIsBniI4Wche2VyQSMYWE5HOjlPBX2OnvZqSvDiYV-ibzfXX68-VbdfPn6-en9bGSbqXGljetaYQy96WzyYBm14y1Vd17otT9KKrrGm65RVRNAGeKsaxqmlTNdCH9gler35LjH8WCFlObtkYJqUh7AmyQhvKO14Iwr66gFd9QxWLtHNKt7Lx0QL8HYDTAwpReilcflPgDkqN0lK5Kk-eZRbffJUn9zqK2L-l_jR_z-yd5sMSkh3DqJMxoE3YF0JNUsb3L8NfgPa3buV
CitedBy_id crossref_primary_10_1111_vco_13042
Cites_doi 10.1038/s42003-020-01590-0
10.1093/carcin/bgr293
10.1002/cncr.33195
10.1016/j.matbio.2017.10.005
10.1371/journal.pone.0134111
10.18632/oncotarget.191
10.1186/1756-9966-29-6
10.18632/oncotarget.173
10.1152/ajpcell.00016.2022
10.1002/cbf.3445
10.3389/fonc.2021.801801
10.1038/sj.onc.1208329
10.1007/s10719-017-9780-9
10.1038/s41598-020-69787-1
10.1016/j.cca.2019.01.003
10.1158/1078-0432.CCR-21-1779
10.1002/mc.22427
10.1016/j.canlet.2008.10.015
10.1089/scd.2008.0338
10.2353/ajpath.2008.080275
10.1038/s41388-021-01773-x
10.1038/s41388-022-02290-1
10.3390/ijms241713596
10.2217/imt.14.108
10.1016/j.stem.2014.11.012
ContentType Journal Article
Copyright 2024 Elsevier B.V.
Copyright © 2024 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2024 Elsevier B.V.
– notice: Copyright © 2024 Elsevier B.V. All rights reserved.
DBID 6I.
AAFTH
AAYXX
CITATION
NPM
7X8
DOI 10.1016/j.bbadis.2024.167181
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList PubMed

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Biology
EISSN 1879-260X
ExternalDocumentID 38653361
10_1016_j_bbadis_2024_167181
S0925443924001704
Genre Journal Article
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
23N
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
6I.
7-5
71M
8P~
9JM
AAEDT
AAEDW
AAFTH
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABEFU
ABFNM
ABGSF
ABMAC
ABMZM
ABUDA
ABWVN
ABXDB
ACDAQ
ACIEU
ACIUM
ACRLP
ACRPL
ADBBV
ADEZE
ADMUD
ADNMO
ADUVX
ADVLN
AEBSH
AEHWI
AEIPS
AEKER
AEXQZ
AFJKZ
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGRNS
AGUBO
AGYEJ
AHHHB
AIEXJ
AIIUN
AIKHN
AITUG
AJRQY
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
EBS
EFJIC
EJD
EO8
EO9
EP2
EP3
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HLW
HVGLF
HZ~
IHE
IXB
J1W
KOM
LX3
M41
MO0
N9A
O-L
O9-
OAUVE
OK1
OZT
P-8
P-9
PC.
Q38
R2-
ROL
RPZ
SBG
SDF
SDG
SDP
SES
SEW
SPCBC
SSH
SSU
SSZ
T5K
UQL
WUQ
XJT
XPP
~G-
AAYXX
CITATION
EFKBS
NPM
7X8
ID FETCH-LOGICAL-c362t-bccf35c7f6fdece3bebc484a222b8f6f08695dc99ada0615e48a5341d13b26b73
IEDL.DBID IXB
ISSN 0925-4439
1879-260X
IngestDate Fri Jul 11 15:35:59 EDT 2025
Mon Jul 21 06:04:27 EDT 2025
Thu Jul 03 08:45:22 EDT 2025
Thu Apr 24 22:57:25 EDT 2025
Sat Jul 05 17:10:27 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Malignant peripheral nerve sheath tumor (MPNST)
Stemness
Decorin
Cancer stem cells (CSCs)
Cancer metastasis
Language English
License This article is made available under the Elsevier license.
Copyright © 2024 Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c362t-bccf35c7f6fdece3bebc484a222b8f6f08695dc99ada0615e48a5341d13b26b73
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S0925443924001704
PMID 38653361
PQID 3045119456
PQPubID 23479
ParticipantIDs proquest_miscellaneous_3045119456
pubmed_primary_38653361
crossref_citationtrail_10_1016_j_bbadis_2024_167181
crossref_primary_10_1016_j_bbadis_2024_167181
elsevier_sciencedirect_doi_10_1016_j_bbadis_2024_167181
PublicationCentury 2000
PublicationDate 2024-06-01
PublicationDateYYYYMMDD 2024-06-01
PublicationDate_xml – month: 06
  year: 2024
  text: 2024-06-01
  day: 01
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Biochimica et biophysica acta. Molecular basis of disease
PublicationTitleAlternate Biochim Biophys Acta Mol Basis Dis
PublicationYear 2024
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Diehl, Huber, Trebicka, Wygrecka, Iozzo, Schaefer (bb0030) 2021; 11
Kemper, Grandela, Medema (bb0045) 2010; 1
Buraschi, Neill, Iozzo (bb0035) 2019; 75-76
Gu, Zhang, Wu, Xu, Cui, Yang, Zhao, Sun (bb0085) 2010; 29
Farace, Oliver, Melguizo, Alvarez, Bandiera, Rama, Malaguarnera, Ortiz, Madeddu, Prados (bb0100) 2015; 10
Hu, Villodre, Larson, Rahal, Wang, Gong, Song, Krishnamurthy, Ueno, Tripathy, Woodward, Debeb (bb0070) 2021; 4
Bi, Xia, Fan, Mu, Zhang, Iozzo, Yang (bb0110) 2016; 55
Xie, Mondal, Ulas, Neill, Iozzo (bb0025) 2022; 322
Voigt, Quelle (bb0020) 2023; 24
Oldham, Berinstein, Medin (bb0130) 2015; 7
Curtin, Lorenzi (bb0040) 2010; 1
Goldoni, Seidler, Heath, Fassan, Baffa, Thakur, Owens, McQuillan, Iozzo (bb0075) 2008; 173
Mallard, Tiralongo (bb0055) 2017; 34
Appunni, Anand, Khandelwal, Gupta, Rubens, Sharma (bb0065) 2019; 491
Wu, Wu (bb0060) 2009; 18
Manji, Van Tine, Lee, Raufi, Pellicciotta, Hirbe, Pradhan, Chen, Rabadan, Schwartz (bb0010) 2021; 27
Thomson, Pundavela, Perrino, Coover, Choi, Chaney, Rizvi, Largaespada, Ratner (bb0120) 2021; 40
Vougiouklakis, Aung, Vasudevaraja, Prieto, Torres-Cabala, Sulman, Snuderl, Jour (bb0125) 2020; 10
Reed, Waterhouse, Kirby, Kay, Owens, McQuillan, Iozzo (bb0080) 2005; 24
Zeuner, Todaro, Stassi, De Maria (bb0050) 2014; 15
Salnikov, Kusumawidjaja, Rausch, Bruns, Gross, Khamidjanov, Ryschich, Gebhard, Moldenhauer, Buchler, Schemmer, Herr (bb0090) 2009; 275
Deng, Xue, Xu, Wang, Wei, Ke, Wang, Chen (bb0105) 2020; 38
Somatilaka, Sadek, McKay, Le (bb0005) 2022; 41
Bi, Pohl, Qian, Yang, Gou, Guzman, Kajdacsy-Balla, Iozzo, Yang (bb0115) 2012; 33
Abdou Hassan, Muqresh, Omer (bb0095) 2022; 14
Geller, Pressey, Smith, Kudgus, Cajaiba, Reid, Hall, Barkauskas, Voss, Cho, Berg, Dome, Fox, Weigel (bb0015) 2020; 126
Kemper (10.1016/j.bbadis.2024.167181_bb0045) 2010; 1
Salnikov (10.1016/j.bbadis.2024.167181_bb0090) 2009; 275
Buraschi (10.1016/j.bbadis.2024.167181_bb0035) 2019; 75-76
Xie (10.1016/j.bbadis.2024.167181_bb0025) 2022; 322
Voigt (10.1016/j.bbadis.2024.167181_bb0020) 2023; 24
Geller (10.1016/j.bbadis.2024.167181_bb0015) 2020; 126
Goldoni (10.1016/j.bbadis.2024.167181_bb0075) 2008; 173
Reed (10.1016/j.bbadis.2024.167181_bb0080) 2005; 24
Vougiouklakis (10.1016/j.bbadis.2024.167181_bb0125) 2020; 10
Manji (10.1016/j.bbadis.2024.167181_bb0010) 2021; 27
Oldham (10.1016/j.bbadis.2024.167181_bb0130) 2015; 7
Appunni (10.1016/j.bbadis.2024.167181_bb0065) 2019; 491
Curtin (10.1016/j.bbadis.2024.167181_bb0040) 2010; 1
Abdou Hassan (10.1016/j.bbadis.2024.167181_bb0095) 2022; 14
Deng (10.1016/j.bbadis.2024.167181_bb0105) 2020; 38
Somatilaka (10.1016/j.bbadis.2024.167181_bb0005) 2022; 41
Diehl (10.1016/j.bbadis.2024.167181_bb0030) 2021; 11
Gu (10.1016/j.bbadis.2024.167181_bb0085) 2010; 29
Wu (10.1016/j.bbadis.2024.167181_bb0060) 2009; 18
Mallard (10.1016/j.bbadis.2024.167181_bb0055) 2017; 34
Farace (10.1016/j.bbadis.2024.167181_bb0100) 2015; 10
Hu (10.1016/j.bbadis.2024.167181_bb0070) 2021; 4
Bi (10.1016/j.bbadis.2024.167181_bb0110) 2016; 55
Bi (10.1016/j.bbadis.2024.167181_bb0115) 2012; 33
Thomson (10.1016/j.bbadis.2024.167181_bb0120) 2021; 40
Zeuner (10.1016/j.bbadis.2024.167181_bb0050) 2014; 15
References_xml – volume: 34
  start-page: 441
  year: 2017
  end-page: 452
  ident: bb0055
  article-title: Cancer stem cell marker glycosylation: nature, function and significance
  publication-title: Glycoconj. J.
– volume: 15
  start-page: 692
  year: 2014
  end-page: 705
  ident: bb0050
  article-title: Colorectal cancer stem cells: from the crypt to the clinic
  publication-title: Cell Stem Cell
– volume: 322
  start-page: C554
  year: 2022
  end-page: C566
  ident: bb0025
  article-title: Oncosuppressive roles of decorin through regulation of multiple receptors and diverse signaling pathways
  publication-title: Am. J. Physiol. Cell Physiol.
– volume: 29
  start-page: 6
  year: 2010
  ident: bb0085
  article-title: Differential expression of decorin, EGFR and cyclin D1 during mammary gland carcinogenesis in TA2 mice with spontaneous breast cancer
  publication-title: J. Exp. Clin. Cancer Res.
– volume: 4
  start-page: 72
  year: 2021
  ident: bb0070
  article-title: Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer
  publication-title: Commun. Biol.
– volume: 173
  start-page: 844
  year: 2008
  end-page: 855
  ident: bb0075
  article-title: An antimetastatic role for decorin in breast cancer
  publication-title: Am. J. Pathol.
– volume: 10
  year: 2020
  ident: bb0125
  article-title: Correlative study of epigenetic regulation of tumor microenvironment in spindle cell melanomas and cutaneous malignant peripheral nerve sheath tumors
  publication-title: Sci. Rep.
– volume: 33
  start-page: 326
  year: 2012
  end-page: 330
  ident: bb0115
  article-title: Decorin-mediated inhibition of colorectal cancer growth and migration is associated with E-cadherin in vitro and in mice
  publication-title: Carcinogenesis
– volume: 27
  start-page: 5519
  year: 2021
  end-page: 5527
  ident: bb0010
  article-title: A phase I study of the combination of Pexidartinib and Sirolimus to target tumor-associated macrophages in Unresectable sarcoma and malignant peripheral nerve sheath tumors
  publication-title: Clin. Cancer Res.
– volume: 11
  year: 2021
  ident: bb0030
  article-title: The role of Decorin and Biglycan signaling in tumorigenesis
  publication-title: Front. Oncol.
– volume: 18
  start-page: 1127
  year: 2009
  end-page: 1134
  ident: bb0060
  article-title: CD133 as a marker for cancer stem cells: progresses and concerns
  publication-title: Stem Cells Dev.
– volume: 7
  start-page: 271
  year: 2015
  end-page: 284
  ident: bb0130
  article-title: Lentiviral vectors in cancer immunotherapy
  publication-title: Immunotherapy
– volume: 24
  year: 2023
  ident: bb0020
  article-title: FOXM1, MEK, and CDK4/6: new targets for malignant peripheral nerve sheath tumor therapy
  publication-title: Int. J. Mol. Sci.
– volume: 40
  start-page: 4229
  year: 2021
  end-page: 4241
  ident: bb0120
  article-title: WNT5A inhibition alters the malignant peripheral nerve sheath tumor microenvironment and enhances tumor growth
  publication-title: Oncogene
– volume: 10
  year: 2015
  ident: bb0100
  article-title: Microenvironmental modulation of Decorin and Lumican in Temozolomide-resistant glioblastoma and neuroblastoma Cancer stem-like cells
  publication-title: PloS One
– volume: 24
  start-page: 1104
  year: 2005
  end-page: 1110
  ident: bb0080
  article-title: Decorin prevents metastatic spreading of breast cancer
  publication-title: Oncogene
– volume: 55
  start-page: 1786
  year: 2016
  end-page: 1795
  ident: bb0110
  article-title: Oncogenic activin C interacts with decorin in colorectal cancer in vivo and in vitro
  publication-title: Mol. Carcinog.
– volume: 75-76
  start-page: 260
  year: 2019
  end-page: 270
  ident: bb0035
  article-title: Decorin is a devouring proteoglycan: remodeling of intracellular catabolism via autophagy and mitophagy
  publication-title: Matrix Biol.
– volume: 41
  start-page: 2405
  year: 2022
  end-page: 2421
  ident: bb0005
  article-title: Malignant peripheral nerve sheath tumor: models, biology, and translation
  publication-title: Oncogene
– volume: 14
  year: 2022
  ident: bb0095
  article-title: The potential role of CD44 and CD133 in colorectal stem cell cancer
  publication-title: Cureus
– volume: 275
  start-page: 185
  year: 2009
  end-page: 193
  ident: bb0090
  article-title: Cancer stem cell marker expression in hepatocellular carcinoma and liver metastases is not sufficient as single prognostic parameter
  publication-title: Cancer Lett.
– volume: 491
  start-page: 1
  year: 2019
  end-page: 7
  ident: bb0065
  article-title: Small leucine rich proteoglycans (decorin, biglycan and lumican) in cancer
  publication-title: Clin. Chim. Acta
– volume: 1
  start-page: 387
  year: 2010
  end-page: 395
  ident: bb0045
  article-title: Molecular identification and targeting of colorectal cancer stem cells
  publication-title: Oncotarget
– volume: 38
  start-page: 47
  year: 2020
  end-page: 57
  ident: bb0105
  article-title: Chrysophanol exhibits inhibitory activities against colorectal cancer by targeting decorin
  publication-title: Cell Biochem. Funct.
– volume: 126
  start-page: 5303
  year: 2020
  end-page: 5310
  ident: bb0015
  article-title: ADVL1522: a phase 2 study of lorvotuzumab mertansine (IMGN901) in children with relapsed or refractory wilms tumor, rhabdomyosarcoma, neuroblastoma, pleuropulmonary blastoma, malignant peripheral nerve sheath tumor, or synovial sarcoma-a Children’s oncology group study
  publication-title: Cancer
– volume: 1
  start-page: 552
  year: 2010
  end-page: 566
  ident: bb0040
  article-title: Drug discovery approaches to target Wnt signaling in cancer stem cells
  publication-title: Oncotarget
– volume: 4
  start-page: 72
  issue: 1
  year: 2021
  ident: 10.1016/j.bbadis.2024.167181_bb0070
  article-title: Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer
  publication-title: Commun. Biol.
  doi: 10.1038/s42003-020-01590-0
– volume: 33
  start-page: 326
  issue: 2
  year: 2012
  ident: 10.1016/j.bbadis.2024.167181_bb0115
  article-title: Decorin-mediated inhibition of colorectal cancer growth and migration is associated with E-cadherin in vitro and in mice
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgr293
– volume: 126
  start-page: 5303
  issue: 24
  year: 2020
  ident: 10.1016/j.bbadis.2024.167181_bb0015
  publication-title: Cancer
  doi: 10.1002/cncr.33195
– volume: 75-76
  start-page: 260
  year: 2019
  ident: 10.1016/j.bbadis.2024.167181_bb0035
  article-title: Decorin is a devouring proteoglycan: remodeling of intracellular catabolism via autophagy and mitophagy
  publication-title: Matrix Biol.
  doi: 10.1016/j.matbio.2017.10.005
– volume: 10
  issue: 7
  year: 2015
  ident: 10.1016/j.bbadis.2024.167181_bb0100
  article-title: Microenvironmental modulation of Decorin and Lumican in Temozolomide-resistant glioblastoma and neuroblastoma Cancer stem-like cells
  publication-title: PloS One
  doi: 10.1371/journal.pone.0134111
– volume: 1
  start-page: 552
  issue: 7
  year: 2010
  ident: 10.1016/j.bbadis.2024.167181_bb0040
  article-title: Drug discovery approaches to target Wnt signaling in cancer stem cells
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.191
– volume: 29
  start-page: 6
  issue: 1
  year: 2010
  ident: 10.1016/j.bbadis.2024.167181_bb0085
  article-title: Differential expression of decorin, EGFR and cyclin D1 during mammary gland carcinogenesis in TA2 mice with spontaneous breast cancer
  publication-title: J. Exp. Clin. Cancer Res.
  doi: 10.1186/1756-9966-29-6
– volume: 14
  issue: 10
  year: 2022
  ident: 10.1016/j.bbadis.2024.167181_bb0095
  article-title: The potential role of CD44 and CD133 in colorectal stem cell cancer
  publication-title: Cureus
– volume: 1
  start-page: 387
  issue: 6
  year: 2010
  ident: 10.1016/j.bbadis.2024.167181_bb0045
  article-title: Molecular identification and targeting of colorectal cancer stem cells
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.173
– volume: 322
  start-page: C554
  issue: 3
  year: 2022
  ident: 10.1016/j.bbadis.2024.167181_bb0025
  article-title: Oncosuppressive roles of decorin through regulation of multiple receptors and diverse signaling pathways
  publication-title: Am. J. Physiol. Cell Physiol.
  doi: 10.1152/ajpcell.00016.2022
– volume: 38
  start-page: 47
  issue: 1
  year: 2020
  ident: 10.1016/j.bbadis.2024.167181_bb0105
  article-title: Chrysophanol exhibits inhibitory activities against colorectal cancer by targeting decorin
  publication-title: Cell Biochem. Funct.
  doi: 10.1002/cbf.3445
– volume: 11
  year: 2021
  ident: 10.1016/j.bbadis.2024.167181_bb0030
  article-title: The role of Decorin and Biglycan signaling in tumorigenesis
  publication-title: Front. Oncol.
  doi: 10.3389/fonc.2021.801801
– volume: 24
  start-page: 1104
  issue: 6
  year: 2005
  ident: 10.1016/j.bbadis.2024.167181_bb0080
  article-title: Decorin prevents metastatic spreading of breast cancer
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1208329
– volume: 34
  start-page: 441
  issue: 4
  year: 2017
  ident: 10.1016/j.bbadis.2024.167181_bb0055
  article-title: Cancer stem cell marker glycosylation: nature, function and significance
  publication-title: Glycoconj. J.
  doi: 10.1007/s10719-017-9780-9
– volume: 10
  issue: 1
  year: 2020
  ident: 10.1016/j.bbadis.2024.167181_bb0125
  article-title: Correlative study of epigenetic regulation of tumor microenvironment in spindle cell melanomas and cutaneous malignant peripheral nerve sheath tumors
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-020-69787-1
– volume: 491
  start-page: 1
  year: 2019
  ident: 10.1016/j.bbadis.2024.167181_bb0065
  article-title: Small leucine rich proteoglycans (decorin, biglycan and lumican) in cancer
  publication-title: Clin. Chim. Acta
  doi: 10.1016/j.cca.2019.01.003
– volume: 27
  start-page: 5519
  issue: 20
  year: 2021
  ident: 10.1016/j.bbadis.2024.167181_bb0010
  article-title: A phase I study of the combination of Pexidartinib and Sirolimus to target tumor-associated macrophages in Unresectable sarcoma and malignant peripheral nerve sheath tumors
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-21-1779
– volume: 55
  start-page: 1786
  issue: 11
  year: 2016
  ident: 10.1016/j.bbadis.2024.167181_bb0110
  article-title: Oncogenic activin C interacts with decorin in colorectal cancer in vivo and in vitro
  publication-title: Mol. Carcinog.
  doi: 10.1002/mc.22427
– volume: 275
  start-page: 185
  issue: 2
  year: 2009
  ident: 10.1016/j.bbadis.2024.167181_bb0090
  article-title: Cancer stem cell marker expression in hepatocellular carcinoma and liver metastases is not sufficient as single prognostic parameter
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2008.10.015
– volume: 18
  start-page: 1127
  issue: 8
  year: 2009
  ident: 10.1016/j.bbadis.2024.167181_bb0060
  article-title: CD133 as a marker for cancer stem cells: progresses and concerns
  publication-title: Stem Cells Dev.
  doi: 10.1089/scd.2008.0338
– volume: 173
  start-page: 844
  issue: 3
  year: 2008
  ident: 10.1016/j.bbadis.2024.167181_bb0075
  article-title: An antimetastatic role for decorin in breast cancer
  publication-title: Am. J. Pathol.
  doi: 10.2353/ajpath.2008.080275
– volume: 40
  start-page: 4229
  issue: 24
  year: 2021
  ident: 10.1016/j.bbadis.2024.167181_bb0120
  article-title: WNT5A inhibition alters the malignant peripheral nerve sheath tumor microenvironment and enhances tumor growth
  publication-title: Oncogene
  doi: 10.1038/s41388-021-01773-x
– volume: 41
  start-page: 2405
  issue: 17
  year: 2022
  ident: 10.1016/j.bbadis.2024.167181_bb0005
  article-title: Malignant peripheral nerve sheath tumor: models, biology, and translation
  publication-title: Oncogene
  doi: 10.1038/s41388-022-02290-1
– volume: 24
  issue: 17
  year: 2023
  ident: 10.1016/j.bbadis.2024.167181_bb0020
  article-title: FOXM1, MEK, and CDK4/6: new targets for malignant peripheral nerve sheath tumor therapy
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms241713596
– volume: 7
  start-page: 271
  issue: 3
  year: 2015
  ident: 10.1016/j.bbadis.2024.167181_bb0130
  article-title: Lentiviral vectors in cancer immunotherapy
  publication-title: Immunotherapy
  doi: 10.2217/imt.14.108
– volume: 15
  start-page: 692
  issue: 6
  year: 2014
  ident: 10.1016/j.bbadis.2024.167181_bb0050
  article-title: Colorectal cancer stem cells: from the crypt to the clinic
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2014.11.012
SSID ssj0000670
Score 2.436359
Snippet Cancer stem cells (CSCs) play pivotal roles in the growth, invasion, metastasis, chemo-resistance in malignant peripheral nerve sheath tumor (MPNST). The...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 167181
SubjectTerms Cancer metastasis
Cancer stem cells (CSCs)
Decorin
Malignant peripheral nerve sheath tumor (MPNST)
Stemness
Title Decorin suppresses stemness and migration potential of malignant peripheral nerve sheath tumor through inhibiting epidermal growth factor receptor signaling
URI https://dx.doi.org/10.1016/j.bbadis.2024.167181
https://www.ncbi.nlm.nih.gov/pubmed/38653361
https://www.proquest.com/docview/3045119456
Volume 1870
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKEYILggJleayMxDXdOnYc51gWquVVIaDS3iw7drZBu0nUzR648Ev4sczYSQWHqhKnPGQnVsb5Zpx88w0hr1WelhDlF4lnViZCpS4xpQODcH_MHVMyKzBR-POZXJyLD8tsuUfmYy4M0ioH7I-YHtB6ODMbnuasq-vZt-MC5bXAv4sgAoOaoFyokMS3fPM3GofvLNA4wdZj-lzgeFlrXI2i3ak4YhJgml3nnq4LP4MbOn1A7g_xIz2JQ3xI9nxzQO7EipI_D8jd-VjA7RH5_RaXlnVDt7su0F39lqJsM4IbNY2jm3oV7U-7tkfWEFy4regGQvMV8mMoqiAH2YE1bZAZSbcI3Re0323aSzqU-KF1c1HbGunT1GO9WYD6NV3B8h5axnI-FB6x73AH6SIGM-Afk_PTd9_ni2QoxpCU4OP6xJZlxbMyr2TloA-33pZCCQPxhVVwEpZGRebKojDOYJjkhTIZuEjHuE2lzfkTst-0jX9KqOTSAnaYTLpcOMFMyrxSorJwBZ9yMSF8tIEuB6VyLJix1iMl7YeOltNoOR0tNyHJVa8uKnXc0D4fzav_mXEanMkNPV-Ns0GDSfEPi2l8u9tq_O3MWAFB6YQcxmlyNRYsrsq5ZM_--77PyT08ikS1F2S_v9z5lxAS9XZKbh39YlNy-2T-9dMX3L7_uDibhjfhD163ERo
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwEB2VItReEBQoy6eRuIatY8dJjrBQbaHthVbam2XHzjZoN4m62UP_Cz-WmTip4FBV4hYldmJ5Rm_G8fM8gI9ZGheY5eeR51ZFMotdZAqHBhH-SDieqSSng8Jn52p-Kb8vksUOzMazMESrHLA_YHqP1sOd6TCb07aqpj-PciqvhfFd9kVg5AN4iNlASvoNJ4svf8Nx_6MFW0fUfDw_15O8rDWuoqrdsfzEFeI0vys-3ZV_9nHo-Ak8HhJI9jmM8Sns-PoAHgVJyZsD2JuNCm7P4PdXWltWNdts257v6jeM6jYTujFTO7aulsEBWNt0RBvCFzclW2NuviSCDKMyyH3dgRWriRrJNoTdV6zbrptrNmj8sKq-qmxF_GnmSXAWsX7Flri-x5ZBz4fhHPuWLogvYugI_HO4PP52MZtHgxpDVGCQ6yJbFKVIirRUpcM-wnpbyEwaTDBshjdxbZQnrshz4wzlSV5mJsEY6biwsbKpeAG7dVP7l8CUUBbBwyTKpdJJbmLus0yWFt_gYyEnIEYb6GIoVU6KGSs9ctJ-6WA5TZbTwXITiG57taFUxz3t09G8-h-X0xhN7un5YfQGjSalLRZT-2a70bTvzHmOfjiBw-Amt2MhdVUhFH_13999D3vzi7NTfXpy_uM17NOTwFp7A7vd9da_xfyos-96__8DlcMQGA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Decorin+suppresses+stemness+and+migration+potential+of+malignant+peripheral+nerve+sheath+tumor+through+inhibiting+epidermal+growth+factor+receptor+signaling&rft.jtitle=Biochimica+et+biophysica+acta.+Molecular+basis+of+disease&rft.au=Jia%2C+Xiaotian&rft.au=Chen%2C+Lin&rft.au=Yu%2C+Cong&rft.date=2024-06-01&rft.eissn=1879-260X&rft.volume=1870&rft.issue=5&rft.spage=167181&rft_id=info:doi/10.1016%2Fj.bbadis.2024.167181&rft_id=info%3Apmid%2F38653361&rft.externalDocID=38653361
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0925-4439&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0925-4439&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0925-4439&client=summon